ArticleExperimental and therapeutic medicine2022

PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells.

Zhengjiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.